SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancerYibo Xue, Sidong Huang|Nature Communications|2019Cited by 189
<scp>SMARCB1</scp> loss induces druggable cyclin <scp>D1</scp> deficiency via upregulation of <scp><i>MIR17HG</i></scp> in atypical teratoid rhabdoid tumorsYibo Xue, Sidong Huang|The Journal of Pathology|2020Cited by 19